Stryker Boosts Full-Year EPS Outlook After Strong Device Sales; Flags Tariff Headwind
Stryker raised its full-year earnings-per-share guidance after posting better-than-expected adjusted fourth-quarter profit and revenue driven by implants and surgical devices. Management said tariffs will add about $400 million of costs in 2026 - roughly $200 million more than the prior year - and that impact will be felt in the first half, while t…